Carret Asset Management’s Pacific Biosciences PACB Stock Holding History

Carret Asset Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	600,140 +41,000	+7%	+$59.6K	0.09%	158
2026 Q1	$738K	Buy	559,140 +89,140	+19%	+$159K	0.07%	174
2025 Q4	$879K	Buy	470,000 +50,000	+12%	+$96.1K	0.08%	160
2025 Q3	$538K	Buy	420,000 +105,000	+33%	+$142K	0.05%	197
2025 Q2	$391K	Buy	+315,000	New	+$364K	0.04%	213
2025 Q1	–	Sell	-215,000	Closed	-$393K	–	281
2024 Q4	$393K	Buy	215,000 +52,000	+32%	+$102K	0.04%	210
2024 Q3	$277K	Buy	163,000 +85,400	+110%	+$140K	0.03%	238
2024 Q2	$106K	Buy	77,600 +45,600	+143%	+$92.1K	0.01%	269
2024 Q1	$120K	Buy	32,000 +11,000	+52%	+$64.4K	0.01%	272
2023 Q4	$206K	Buy	21,000 +4,000	+24%	+$32.7K	0.03%	262
2023 Q3	$142K	Hold	17,000	–	–	0.02%	260
2023 Q2	$226K	Hold	17,000	–	–	0.03%	242
2023 Q1	$197K	Hold	17,000	–	–	0.03%	252
2022 Q4	$139K	Hold	17,000	–	–	0.02%	267
2022 Q3	$99K	Buy	17,000 +5,000	+42%	+$28.7K	0.01%	265
2022 Q2	$53K	Buy	+12,000	New	+$72.9K	0.01%	273
2019 Q2	–	Sell	-10,000	Closed	-$72K	–	274
2019 Q1	$72K	Sell	10,000 -10,000	-50%	-$72.3K	0.01%	258
2018 Q4	$148K	Hold	20,000	–	–	0.03%	245
2018 Q3	$108K	Hold	20,000	–	–	0.02%	264
2018 Q2	$71K	Buy	20,000 +3,000	+18%	+$8.32K	0.01%	259
2018 Q1	$35K	Buy	+17,000	New	+$44.1K	0.01%	257

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Carret Asset Management's PACB Position: Q2 2026 in Review

Carret Asset Management increased its Pacific Biosciences (PACB) stake by 7.3% in Q2 2026, buying an estimated $59.6K and bringing the position to 600,140 shares worth $1.01M. The position accounts for 0.09% of the portfolio, ranked #158.

Carret Asset Management first reported a position in PACB in Q1 2018 and has held it in 21 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Carret Asset Management held 600,140 shares of Pacific Biosciences worth $1.01M as of Q2 2026.
Carret Asset Management bought 41,000 Pacific Biosciences shares in Q2 2026, an estimated $59.6K.
Pacific Biosciences made up 0.09% of Carret Asset Management's portfolio in Q2 2026, its #158 holding.
Carret Asset Management first reported a position in Pacific Biosciences in Q1 2018 and has held it in 21 quarters since.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Carret Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.